Your Patient Is Taking Belatacept and Develops Posttransplant Lymphoproliferative Disorder

Your patient is taking belatacept and develops posttransplant lymphoproliferative disorder (PTLD) . PTLD primarily affects:

A) the liver
B) the heart
C) the kidneys
D) the nervous system

Correct Answer:

Verified

Show Answer